…and some to hold, avoid or sell

BT Group The Times

Shares in the telecoms giant are at a four-year low, not helped by its “murky international arm”, which has housed a “massive fraud” at BT Italia. With a “gigantic” £7.7bn pension deficit, the dividend is vulnerable. Sell. 253.5p.

Centrica Shares

The British Gas owner bears the weight of regulatory millstones and “weak upstream dynamics”. The Government’s planned energy price cap will put a drag on future earnings. Shares may fall further. Sell. 169.75p.

Glaxosmithkline Investors Chronicle

Revenue from GSK’S new medicines is weak: its asthma drug, Advair, faces generic competition, and the pipeline is “uncomfortably empty”. The dividend is at risk if GSK buys Pfizer’s consumer healthcare arm. Sell. £13.52.

Inmarsat The Sunday Times

A “constellation” of problems has hit shares in the satellite broadband provider, despite a pipeline of contracts from commercial airlines. Squeezed margins and cash burn will affect the dividend. Avoid. 594.5p.

Kingfisher Shares

The home improvement firm’s “soggy” share price reflects a cautious outlook for the UK and France, and doubts about the transformation plan. DIY is dwindling, and competition is increasing from the reinvigorated Homebase. Sell. 310p.

WPP Investors Chronicle

The advertising conglomerate is struggling, with lower corporate spending bringing lower revenues. Competition has escalated, and debt has risen with acquisitions. Margins are under pressure. Sell. £13.28